NYSE:UPH
UpHealth, Inc.
- Stock
Last Close
0.27
11/12 21:00
Market Cap
5.33M
Beta: 0.65
Volume Today
348.73K
Avg: 50.12K
PE Ratio
−0.07
PFCF: −0.18
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '19 | Dec '20 | Dec '21 | Dec '22 | ||
---|---|---|---|---|---|
average inventory | 58.50K - | 1.52M 2,502.56% | 1.54M 1.44% | ||
average payables | 1.34M - | 8.14M 507.61% | 15.79M 93.98% | ||
average receivables | 3.35M - | 14.75M 340.16% | 22.33M 51.39% | ||
book value per share | 18.77 - | 29.75 58.54% | 7.15 75.96% | ||
capex per share | -0.35 - | -0.31 10.60% | |||
capex to depreciation | -0.22 - | -0.20 7.83% | |||
capex to operating cash flow | 0.06 - | 0.19 219.52% | |||
capex to revenue | -0.03 - | -0.03 4.29% | |||
cash per share | 14.47 - | 5.44 62.44% | 1.06 80.53% | ||
days of inventory on hand | 36.10 - | 13.32 63.09% | 0.66 95.02% | ||
days payables outstanding | 826.88 - | 61.91 92.51% | 74.04 19.60% | ||
days sales outstanding | 453.41 - | 67.23 85.17% | 50.26 25.25% | ||
debt to assets | 0.09 - | 0.21 140.38% | 0.46 117.16% | ||
debt to equity | 0.11 - | 0.38 261.48% | 1.50 292.58% | ||
dividend yield | |||||
earnings yield | -0.00 - | -1.42 86,661.74% | -9.30 555.46% | ||
enterprise value | 1.31B - | 303.05M 76.85% | 165.89M 45.26% | ||
enterprise value over ebitda | -817.24 - | -11.25 98.62% | -64.15 470.39% | ||
ev to operating cash flow | -1.15K - | -4.82 99.58% | -6.87 42.45% | ||
ev to sales | 242.63 - | 2.45 98.99% | 1.04 57.33% | ||
free cash flow per share | -0.10 - | -6.22 6,319.16% | -1.95 68.58% | ||
free cash flow yield | -0.00 - | -0.28 31,279.35% | -1.20 331.73% | ||
graham net net | 11.36 - | -14.83 230.49% | -13.72 7.49% | ||
graham number | 8.70 - | 145.90 1,577.45% | 49.41 66.14% | ||
income quality | 0.52 - | 0.18 64.63% | 0.11 41.24% | ||
intangibles to total assets | 0 - | 0.73 Infinity% | 0.70 4.07% | 0.56 19.90% | |
interest coverage | -14.37 - | -2.30 84.01% | -0.95 58.87% | ||
interest debt per share | 1.99 - | 13.18 561.34% | 12.52 5.00% | ||
inventory turnover | 10.11 - | 27.39 170.92% | 550.61 1,910.00% | ||
invested capital | 0.11 - | 0.38 261.48% | 1.50 292.58% | ||
market cap | 1.29B - | 239.75M 81.38% | 23.96M 90.01% | ||
net current asset value | 173.99M - | -28.98M 116.66% | -128.72M 344.17% | -190.34M 47.88% | |
net debt to ebitda | -13.39 - | -2.35 82.46% | -54.88 2,236.16% | ||
net income per share | -0.18 - | -31.80 17,648.52% | -15.17 52.30% | ||
operating cash flow per share | -0.10 - | -5.87 5,960.00% | -1.64 72.02% | ||
payables turnover | 0.44 - | 5.90 1,235.68% | 4.93 16.39% | ||
receivables turnover | 0.81 - | 5.43 574.44% | 7.26 33.77% | ||
research and ddevelopement to revenue | 0.16 - | 0.06 63.58% | 0.05 15.79% | ||
return on tangible assets | -0.03 - | -2.01 6,601.22% | -1.50 25.27% | ||
revenue per share | 0.46 - | 11.57 2,420.87% | 10.80 6.59% | ||
roe | -0.01 - | -1.07 11,095.07% | -2.12 98.39% | ||
roic | -0.01 - | -0.10 1,151.79% | -0.09 11.53% | ||
sales general and administrative to revenue | 0.92 - | 0.48 48.16% | 0.35 26.81% | ||
shareholders equity per share | 18.77 - | 29.75 58.54% | 7.15 75.96% | ||
stock based compensation to revenue | 0.01 - | 0.01 42.90% | 0.04 377.92% | ||
tangible asset value | 173.99M - | 28.75M 83.48% | -65.74M 328.69% | -84.90M 29.15% | |
tangible book value per share | 2.44 - | -6.14 351.29% | -5.78 5.96% | ||
working capital | 173.99M - | -22.18M 112.75% | 10.04M 145.28% | -25.56M 354.51% |
All numbers in USD (except ratios and percentages)